The effects of sigma (σ1) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effects of sigma (σ1) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 172, Issue 10, Pages 2519-2531
Publisher
Wiley
Online
2015-01-09
DOI
10.1111/bph.13076
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism
- (2014) Veronica Francardo et al. BRAIN
- The Concise Guide to PHARMACOLOGY 2013/14: Ligand-Gated Ion Channels
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: Overview
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: Ion Channels
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Characterization of the Human Sigma-1 Receptor Chaperone Domain Structure and Binding Immunoglobulin Protein (BiP) Interactions
- (2013) Jose Luis Ortega-Roldan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Brain Sigma-1 Receptor Stimulation Improves Mental Disorder and Cardiac Function in Mice With Myocardial Infarction
- (2013) Koji Ito et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Captodiamine, a putative antidepressant, enhances hypothalamic BDNF expression in vivo by synergistic 5-HT2c receptor antagonism and sigma-1 receptor agonism
- (2013) Rebecca M Ring et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation
- (2013) Marco Peviani et al. NEUROBIOLOGY OF DISEASE
- The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
- (2013) Adam J. Pawson et al. NUCLEIC ACIDS RESEARCH
- Coenzyme Q10 supplementation reverses age-related impairments in spatial learning and lowers protein oxidation
- (2012) Ritu A. Shetty et al. AGE
- Neuroprotective effects of high affinity sigma 1 receptor selective compounds
- (2012) Robert R. Luedtke et al. BRAIN RESEARCH
- Synaptic plasticity of NMDA receptors: mechanisms and functional implications
- (2012) David L Hunt et al. CURRENT OPINION IN NEUROBIOLOGY
- Sigma-1 Receptor Agonists as Therapeutic Drugs for Cognitive Impairment in Neuropsychiatric Diseases
- (2012) Tomihisa Niitsu et al. CURRENT PHARMACEUTICAL DESIGN
- Progesterone Increases the Release of Brain-Derived Neurotrophic Factor from Glia via Progesterone Receptor Membrane Component 1 (Pgrmc1)-Dependent ERK5 Signaling
- (2012) Chang Su et al. ENDOCRINOLOGY
- Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression
- (2012) Kenji Hashimoto PROGRESS IN NEUROBIOLOGY
- Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor
- (2012) Michiko Fujimoto et al. SYNAPSE
- The sigma-1 receptor: roles in neuronal plasticity and disease
- (2012) Saïd Kourrich et al. TRENDS IN NEUROSCIENCES
- The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke
- (2011) Karsten Ruscher et al. BRAIN
- Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders
- (2011) Teruo Hayashi et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Revisiting the cholinergic hypothesis in the development of Alzheimer's disease
- (2011) Laura A. Craig et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- The cholinergic hypothesis of cognitive aging revisited again: Cholinergic functional compensation
- (2011) Julie A. Dumas et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The cholinergic system, sigma-1 receptors and cognition
- (2010) Aren van Waarde et al. BEHAVIOURAL BRAIN RESEARCH
- Guidelines for reporting experiments involving animals: the ARRIVE guidelines
- (2010) JC McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Potential Future Neuroprotective Therapies for Neurodegenerative Disorders and Stroke
- (2010) Rawan Tarawneh et al. CLINICS IN GERIATRIC MEDICINE
- Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma1 (σ1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative
- (2010) Vanessa Villard et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Genistein directly inhibits native and recombinant NMDA receptors
- (2010) Renqi Huang et al. NEUROPHARMACOLOGY
- The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies
- (2010) Inge Klinkenberg et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Anti-amnesic properties of (±)-PPCC, a novel sigma receptor ligand, on cognitive dysfunction induced by selective cholinergic lesion in rats
- (2009) Vuokko Antonini et al. JOURNAL OF NEUROCHEMISTRY
- The pharmacology of sigma-1 receptors
- (2009) Tangui Maurice et al. PHARMACOLOGY & THERAPEUTICS
- The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator
- (2009) D. Fontanilla et al. SCIENCE
- The anti-amnesic and neuroprotective effects of donepezil against amyloid β25-35 peptide-induced toxicity in mice involve an interaction with the σ1 receptor
- (2006) J Meunier et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started